A recent FDA approval means consumers now have to GLP-1 weight loss pills to choose from as an alternative to the traditional ...

Under the new priority voucher program (CNPV), the FDA has approved a new oral GLP-1 drug, Foundayo, offering an alternative ...

The U.S. Food and Drug Administration on Wednesday approved a second oral GLP-1 medication, giving adults eligible for weight ...

Eli Lilly oral GLP-1 weight loss pill Foundayo is now available through Amazon Pharmacy and GoodRx, expanding access for hospitals and patients.

Key Takeaways On April 1, 2026, FDA issued a statement reminding 503A pharmacies and 503B outsourcing facilities that ...

The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a ...

Health researchers with the Cleveland Clinic say the GLP-1 drug, Tirzepatide, may lower health risks such as heart and kidney ...

Eli Lilly’s once-daily Foundayo is the second obesity pill to receive FDA approval. It will compete with Novo Nordisk’s pill ...

*Gulp* Much to the relief of the needle-shy, the FDA has just approved a second oral GLP-1 drug, following the release of the ...

FDA issues guidance compounded GLP-1 production limits, restricting pharmacies to compound only during active shortages to ensure drug safety and ...

Foundayo, a once-daily oral GLP-1 medication approved for obesity and weight-related issues, ranges in cost from $25 to $349 ...

Federal regulators have approved the GLP-1 tablet Foundayo for weight loss. The once-daily oral pill provides an alternative ...